TEVATEVA PHARMACEUTICAL INDS LTD

Buy on Pullback79

Notable Interest

Smart Money Trend

High 82Low 36+13.3 since 22-Q3

View as data table

Quarter	Score
2022-Q3	66.1
2022-Q4	49.6
2023-Q1	49.1
2023-Q2	36.1
2023-Q3	48.8
2023-Q4	51.0
2024-Q1	36.6
2024-Q2	36.9
2024-Q3	78.0
2024-Q4	75.2
2025-Q1	74.0
2025-Q2	79.7
2025-Q3	80.5
2025-Q4	81.6
2026-Q1	67.3
2026-Q2	79.4

Aging — next filings due soon — Q2 2026 • ended Jun 30, 2026 • 13F due ~Aug 14 • 124d old • 16/17 funds filed • latest filing Sep 2 • prices as of 4:58 PM ET

$37.49+44.5%vs tracked

Investor Action VerdictBuy on Pullback

Strong consensus, but price is extended — wait for pullback to funds' basis

Superinvestor Flow

Moderate Accumulation

Why This Verdict

•Consensus score of 79.4/100 (Notable Interest) held by 2 funds.
•Neutral flow: 0 holding steady (1 buys balanced by 1 sells).
•Extended: price has surged +44.5% above funds' basis — elevated risk of buying at local peak.
•Score trend: +12.1 pts vs previous quarter.

Entry Timing & ZoneExtended Risk

Trading +44.5% above funds' purchase price — elevated pullback risk

Current Price:$37.49

Funds' Basis:~$25.95

Target Entry:< $28.55

Aggregate Fund Flow (TEVA)

Moderate Accumulation(+25 score)

Net: 0 funds

1 Buyers(1 new)0 Holds1 Sellers

2 active funds

2 of 18 tracked funds hold TEVA. Avg conviction: 1.3%. Net holding. First tracked at $25.95 (current +44.5% vs tracked).

Am I Late?

44.5% abovetheir avg tracked price

Tracked: $25.95Current: $37.49

Per-fund first tracked prices

Greenlight Capital$18.02(2024-Q3)

Citadel Advisors$33.88(2026-Q2)

How Convicted?

1.3%avg portfolio allocation

Greenlight Capital has 2.5% in this stock

Top 5 (0)Mid (1)Small (1)

Fund breakdown

Greenlight CapitalCitadel Advisors

Which Way Is the Wind Blowing?

Moderate Accumulation(+25 score)

Net: 0 funds

1 Buyers(1 new)0 Holds1 Sellers

2 active funds

Per-fund actions

Greenlight CapitalReduce

Citadel AdvisorsNew Buy

Did It Work?

+59.4%avg return since tracked

S&P 500: +8.5%Alpha: +50.8%

Per-fund returns

Greenlight Capital+108.0%(from $18.02)

Citadel Advisors+10.7%(from $33.88)

About this data

Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.

Pro Feature

Upgrade to Fund Consensus Pro to unlock this feature.

Upgrade to Pro

Fund Holders (2 funds)

Fund	% of Portfolio	Value	First Tracked Price	Action
Greenlight Capital	2.5%	$97.8M	$18.02	Reduce
Citadel Advisors	0.0%	$2.5M	$33.88	New Buy